US 7241783
Thrombopoietin mimetics
granted A61KA61K31/04A61K31/045
Quick answer
US patent 7241783 (Thrombopoietin mimetics) held by Ligand Pharmaceuticals Incorporated expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/04, A61K31/045, A61K31/05, A61K31/13